Hiroshi Sogawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroshi Sogawa has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Kenji Okumura
Westchester Medical Center, Department of Surgery, Valhalla, New York
11 shared publications - Abhay Dhand
Department of Medicine, New York Medical College, Valhalla, NY
9 shared publications - Gregory Veillette
Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY, USA
7 shared publications - Ryosuke Misawa
Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, New York
7 shared publications - Seigo Nishida
Division of Transplant Surgery, Westchester Medical Center, Valhalla, NY
7 shared publications Seigo Nishida
Department of Surgery, Westchester Medical Center, Valhalla, New York
6 shared publications
Latest Publications
- 22 December 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 83 (2) , 103823
Enhancing Medical Student Exposure to Transplantation: The New York Medical College and Westchester Medical Center Transplant Education Program
- 22 December 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 83 (2) , 103823
Enhancing Medical Student Exposure to Transplantation: The New York Medical College and Westchester Medical Center Transplant Education Program
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Transplantation
- Vol. 2025 (1)
A Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report
Despite revolutionary improvements in mortality, cardiovascular events, and quality of life, kidney transplantation has been plagued with perioperative mortality, graft rejection, and immunosuppression‐associated complications, most commonly infections. Fungal infections in particular only account for 5% of all cases but have the worst outcomes, with mortality ranging between 25% and 80% in solid organ transplant recipients. Candida , Cryptococcus , and Aspergillus species are the commonest causative agents, and isolated cases of other species have been reported in other immunosuppressed pathologies. Here, we present the first recorded case of Cyberlindnera jadinii fungemia in a kidney transplant recipient, highlighting the need for close surveillance, early diagnosis, and potentially continuing posttransplant antifungal prophylaxis beyond the current recommended duration.
- 1 January 2025
- Published by Wiley in Case Reports in Transplantation
- Vol. 2025 (1)
Open AccessA Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report
Despite revolutionary improvements in mortality, cardiovascular events, and quality of life, kidney transplantation has been plagued with perioperative mortality, graft rejection, and immunosuppression‐associated complications, most commonly infections. Fungal infections in particular only account for 5% of all cases but have the worst outcomes, with mortality ranging between 25% and 80% in solid organ transplant recipients. Candida , Cryptococcus , and Aspergillus species are the commonest causative agents, and isolated cases of other species have been reported in other immunosuppressed pathologies. Here, we present the first recorded case of Cyberlindnera jadinii fungemia in a kidney transplant recipient, highlighting the need for close surveillance, early diagnosis, and potentially continuing posttransplant antifungal prophylaxis beyond the current recommended duration.
- Open Access
- 5 July 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (8) , e1679
Normothermic Machine Perfusion Is Associated With Improvement in Mortality and Graft Failure in Donation After Cardiac Death Liver Transplant Recipients in the United States
Background.: Use of normothermic machine perfusion (NMP) may help to expand the liver transplantation (LT) donor pool by potentially increasing the utilization of donation after circulatory death (DCD) organs. The aim of this study was to assess the impact of NMP on LT from DCD organs. Methods.: Data among DCD adult LT recipients in the United Network for Organ Sharing between January 2016 and December 2022 were analyzed. Outcomes were compared between 2 groups: NMP versus non-MP using propensity score matching. Results.: During the study period, 4217 DCD LT recipients (NMP: 257 and non-MP: 3960) were identified. compared with non-MP, DCD LT recipients in NMP group were older (median recipient age: 61 versus 59 y, P = 0.013), had lower model for the end-stage liver disease score, longer wait time (126 versus 107 d, P = 0.028), and received organs from older donors (median age: 42 versus 38 y, P < 0.01) with longer preservation time (9.9 versus 5.3 h, P < 0.001). Two-year overall survival (NMP 94.4% versus non-MP 89.7%, P = 0.040) and 2-y graft survival (NMP 91.3% versus non-MP 84.6%, P = 0.017) were better in the NMP group. After propensity score matching, 2-y overall survival (NMP 94.2% versus non-MP 88.0%, P = 0.023) and graft survival (NMP 91.3% versus non-MP 81.6%, P = 0.004) were better in the NMP group. On multivariable cox regression analysis, NMP was an independent factor of protection against mortality (hazard ratio, 0.43; 95% confidence interval: 0.20-0.91; P = 0.029) and against graft failure (hazard ratio, 0.26; 95% confidence interval: 0.11-0.61; P = 0.002). Conclusions.: Use of NMP for LT from DCD donors was associated with improved posttransplant patient and graft survival.
- 5 July 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (8) , e1679
Open AccessNormothermic Machine Perfusion Is Associated With Improvement in Mortality and Graft Failure in Donation After Cardiac Death Liver Transplant Recipients in the United States
Background.: Use of normothermic machine perfusion (NMP) may help to expand the liver transplantation (LT) donor pool by potentially increasing the utilization of donation after circulatory death (DCD) organs. The aim of this study was to assess the impact of NMP on LT from DCD organs. Methods.: Data among DCD adult LT recipients in the United Network for Organ Sharing between January 2016 and December 2022 were analyzed. Outcomes were compared between 2 groups: NMP versus non-MP using propensity score matching. Results.: During the study period, 4217 DCD LT recipients (NMP: 257 and non-MP: 3960) were identified. compared with non-MP, DCD LT recipients in NMP group were older (median recipient age: 61 versus 59 y, P = 0.013), had lower model for the end-stage liver disease score, longer wait time (126 versus 107 d, P = 0.028), and received organs from older donors (median age: 42 versus 38 y, P < 0.01) with longer preservation time (9.9 versus 5.3 h, P < 0.001). Two-year overall survival (NMP 94.4% versus non-MP 89.7%, P = 0.040) and 2-y graft survival (NMP 91.3% versus non-MP 84.6%, P = 0.017) were better in the NMP group. After propensity score matching, 2-y overall survival (NMP 94.2% versus non-MP 88.0%, P = 0.023) and graft survival (NMP 91.3% versus non-MP 81.6%, P = 0.004) were better in the NMP group. On multivariable cox regression analysis, NMP was an independent factor of protection against mortality (hazard ratio, 0.43; 95% confidence interval: 0.20-0.91; P = 0.029) and against graft failure (hazard ratio, 0.26; 95% confidence interval: 0.11-0.61; P = 0.002). Conclusions.: Use of NMP for LT from DCD donors was associated with improved posttransplant patient and graft survival.
- 14 June 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 300, 477-484
Potential Association of Blood Transfusion in Deceased Donors With Outcomes of Liver Transplantation in the United States
- 14 June 2024
- Published by Elsevier in Journal of Surgical Research
- Vol. 300, 477-484
Potential Association of Blood Transfusion in Deceased Donors With Outcomes of Liver Transplantation in the United States
- Open Access
- 5 April 2024
- Published by Elsevier in Surgery in Practice and Science
- Vol. 17, 100245
Indications and outcomes of liver transplantation for liver tumors in the United States
- 5 April 2024
- Published by Elsevier in Surgery in Practice and Science
- Vol. 17, 100245
Open AccessIndications and outcomes of liver transplantation for liver tumors in the United States
- Open Access
- 12 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Use of 50 years or older donors in septuagenarian recipients for liver transplantation: Potential to expand the donor pool
- 12 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Open AccessUse of 50 years or older donors in septuagenarian recipients for liver transplantation: Potential to expand the donor pool
- Open Access
- 1 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Successful liver transplantation from a donor with Swyer–James Syndrome
- 1 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Open AccessSuccessful liver transplantation from a donor with Swyer–James Syndrome
- Open Access
- 25 January 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (2) , 252-261
High Rate of Kidney Graft Failure after Simultaneous Heart–Kidney Transplantation
Key Points: Simultaneous heart–kidney transplant is associated with high rates of kidney graft failure which are worse when compared with kidney transplant alone. The major causes of kidney graft failure in simultaneous heart–kidney transplant recipients were patient death and primary nonfunction of kidney graft. Background: The indications and outcomes of simultaneous heart–kidney transplantation (SHKT) remain suboptimally defined. Risk factors for renal graft failure after SHKT also remain poorly defined. Methods: We analyzed the renal graft outcomes among SHKT recipients using United Network for Organ Sharing database from 2015 to 2020. To evaluate for factors associated with poor renal outcomes, we compared SHKT and kidney transplantation alone recipients using propensity score matching. Results: Among SHKT recipients, the rate of primary nonfunction (PNF) of kidney graft was 3%, the 30-day kidney graft failure rate was 7.0%, and the 30-day post-transplant mortality rate was 4.1%. The incidence of kidney delayed graft function was 27.5%. Kidney graft failure was seen early post-SHKT with most common causes of patient death (43.9%) and PNF of kidney graft (41.5%). One- and 2-year patient survival was 89.2% and 86.5%, and 1- and 2-year freedom from kidney graft failure was 85.4% and 82.7%, respectively. In subgroup analysis of SHKT recipients, use of pretransplant mechanical cardiac support (adjusted odds ratio [aOR], 2.57; P = 0.017), higher calculated panel reactive antibody (aOR, 1.76; P = 0.016), and older donor age per 10 years (aOR, 1.94; P = 0.001) were associated with PNF. Pretransplant extracorporeal membrane oxygenation support was associated with the increased risk of 30-day recipient mortality (aOR, 5.55; P = 0.002). Increased 30-day graft failure was seen in SHKT recipients with pretransplant mechanical cardiac support (aOR, 1.77; P = 0.038) and dialysis at the time of transplant (aOR, 1.72; P = 0.044). Multivariable Cox hazard analysis demonstrated that SHKT, when compared with kidney transplantation alone, is associated with increased kidney graft failure (hazard ratio, 2.56; P < 0.001) and recipient mortality (hazard ratio, 2.65; P < 0.001). Conclusions: SHKT is associated with high rates of kidney graft failure. Identification of risk factors of renal graft failure can help optimize recipient selection for SHKT versus kidney after heart transplantation, especially after introduction of the new safety-net policy.
- 25 January 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (2) , 252-261
Open AccessHigh Rate of Kidney Graft Failure after Simultaneous Heart–Kidney Transplantation
Key Points: Simultaneous heart–kidney transplant is associated with high rates of kidney graft failure which are worse when compared with kidney transplant alone. The major causes of kidney graft failure in simultaneous heart–kidney transplant recipients were patient death and primary nonfunction of kidney graft. Background: The indications and outcomes of simultaneous heart–kidney transplantation (SHKT) remain suboptimally defined. Risk factors for renal graft failure after SHKT also remain poorly defined. Methods: We analyzed the renal graft outcomes among SHKT recipients using United Network for Organ Sharing database from 2015 to 2020. To evaluate for factors associated with poor renal outcomes, we compared SHKT and kidney transplantation alone recipients using propensity score matching. Results: Among SHKT recipients, the rate of primary nonfunction (PNF) of kidney graft was 3%, the 30-day kidney graft failure rate was 7.0%, and the 30-day post-transplant mortality rate was 4.1%. The incidence of kidney delayed graft function was 27.5%. Kidney graft failure was seen early post-SHKT with most common causes of patient death (43.9%) and PNF of kidney graft (41.5%). One- and 2-year patient survival was 89.2% and 86.5%, and 1- and 2-year freedom from kidney graft failure was 85.4% and 82.7%, respectively. In subgroup analysis of SHKT recipients, use of pretransplant mechanical cardiac support (adjusted odds ratio [aOR], 2.57; P = 0.017), higher calculated panel reactive antibody (aOR, 1.76; P = 0.016), and older donor age per 10 years (aOR, 1.94; P = 0.001) were associated with PNF. Pretransplant extracorporeal membrane oxygenation support was associated with the increased risk of 30-day recipient mortality (aOR, 5.55; P = 0.002). Increased 30-day graft failure was seen in SHKT recipients with pretransplant mechanical cardiac support (aOR, 1.77; P = 0.038) and dialysis at the time of transplant (aOR, 1.72; P = 0.044). Multivariable Cox hazard analysis demonstrated that SHKT, when compared with kidney transplantation alone, is associated with increased kidney graft failure (hazard ratio, 2.56; P < 0.001) and recipient mortality (hazard ratio, 2.65; P < 0.001). Conclusions: SHKT is associated with high rates of kidney graft failure. Identification of risk factors of renal graft failure can help optimize recipient selection for SHKT versus kidney after heart transplantation, especially after introduction of the new safety-net policy.
- 21 October 2023
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 14 (2) , 101296
The Effect of New Acuity Circle Policy on Simultaneous Liver and Kidney Transplantation in the United States
- 21 October 2023
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 14 (2) , 101296
The Effect of New Acuity Circle Policy on Simultaneous Liver and Kidney Transplantation in the United States